Skip to main content
Scienza Health
CLINICAL SCREENING
Last updated: April 2026Reviewed quarterly

GIA®, powered by digitalhumanOS™, screens for 46 clinical conditions — 24 live today — across mental health, neurodegenerative, respiratory, metabolic, cardiovascular, and wellness categories. Each screening takes under 5 minutes through a single patient conversation, with results delivered in 60 seconds. FDA-registered.

24 Conditions. Live Now.

46 Conditions. Coming.

One Conversation.

GIA®, powered by digitalhumanOS™, screens for 46 clinical conditions — 24 live today — using Voice AI, Computer Vision, and Speech Biomarkers in a single patient conversation lasting under 5 minutes. Results are delivered in 60 seconds. FDA-registered, pre-bundled on Samsung Health Grade Galaxy devices, and PointClickCare integrated.

Key Facts

Conditions
46
Live Now
24
Screening Time
Under 5 min
Results
60 seconds
Registration
FDA-Registered
Top Accuracy
Depression 81.6%

For medical directors, administrators, directors of nursing, and regional operators.

The most comprehensive multimodal clinical screening platform ever built for post-acute and long-term care.

Tablet showing GIA® on a video call — screening 46 conditions from a single patient conversation
Schedule a Demo
FDA-RegisteredEditorially reviewed·

This content is intended for informational purposes and does not constitute medical advice. Editorially reviewed by David Kaiser, CEO of Scienza Health, for accuracy in post-acute care operations.

Depression

Mental/Behavioral Health81.6% accuracy

PTSD

Mental/Behavioral Health80.0% accuracy

Anxiety

Mental/Behavioral Health77.5% accuracy

Stress-Nervousness

Mental/Behavioral Health77.2% accuracy

Anxiety (Female)

Mental/Behavioral Health76.5% accuracy

Depression (Female)

Mental/Behavioral Health75.4% accuracy

Psychoactive Substance Abuse

Mental/Behavioral Health75.1% accuracy

Fatigue-Malaise

Mental/Behavioral Health71.7% accuracy

ADHD

Mental/Behavioral Health71.6% accuracy

Sleep Disorders

Mental/Behavioral Health70.6% accuracy

Bipolar Disorder

Mental/Behavioral Health65.2% accuracy

Stress

Mental/Behavioral HealthClinically validated vocal biomarker screening

Mood

Mental/Behavioral HealthClinically validated vocal biomarker screening

Energy Levels

Mental/Behavioral HealthClinically validated vocal biomarker screening

Violence & Aggression

Mental/Behavioral HealthClinically validated vocal biomarker screening

Cognitive Decline

Neurodegenerative70.8% accuracy

Alzheimer's Disease

NeurodegenerativeClinically validated vocal biomarker screening

Parkinson's Disease

NeurodegenerativeAUC 0.97 — peer-reviewed

Mild Cognitive Impairment

NeurodegenerativeClinically validated vocal biomarker screening

Huntington's Disease

NeurodegenerativeClinically validated vocal biomarker screening

Vocal Energy

WellnessClinically validated vocal biomarker screening

Anxiety (Male)

Mental/Behavioral Health72.0%

Depression (Male)

Mental/Behavioral Health71.0%

Burnout

Mental/Behavioral Health78.0%
Coming Soon

Vaping-related Disorder

Mental/Behavioral Health
Coming Soon

Traumatic Brain Injury

Neurodegenerative
Coming Soon

Cognitive Impairment/Deficit

Neurodegenerative
Coming Soon

Multiple Sclerosis

Neurodegenerative
Coming Soon

Hearing-related Disorders

Neurodegenerative
Coming Soon

Tobacco Use/Dependence

Respiratory
Coming Soon

Allergic Rhinitis

Respiratory
Coming Soon

Breathing Abnormalities

Respiratory
Coming Soon

Respiratory Infection

Respiratory
Coming Soon

Chronic Lower Respiratory Disease

Respiratory
Coming Soon

COVID-19

Respiratory
Coming Soon

Post-COVID-19

Respiratory
Coming Soon

Tuberculosis

Respiratory
Coming Soon

Type 2 Diabetes

Metabolic
Coming Soon

Obesity

Metabolic
Coming Soon

Dehydration

Metabolic
Coming Soon

Thyroid Disorders

Metabolic
Coming Soon

Ovarian Dysfunction

Women's Health
Coming Soon

Postpartum Depression

Women's Health
Coming Soon

Hypertension

Cardiovascular
Coming Soon

Coronary Artery Disease

Cardiovascular
Coming Soon

Voice Disorders

Other
FREQUENTLY ASKED

Frequently asked questions.

How many conditions does GIA® screen for?

24 conditions are live today with 46 total on the platform. All screening happens through a single patient conversation lasting under 5 minutes.

How accurate is the screening?

Accuracy varies by condition. Depression achieves 81.6% (Journal of Affective Disorders), PTSD 80.0% (Journal of Traumatic Stress), Anxiety 77.5% (Psychological Medicine), and Parkinson's Disease achieves an AUC of 0.97 (Movement Disorders) based on peer-reviewed clinical research.

How long does screening take?

Under 5 minutes of natural patient conversation. Results delivered in 60 seconds. No additional clinician time required.

Is this FDA-registered?

Yes. GIA®, powered by digitalhumanOS™, is FDA-registered, pre-bundled on Samsung Health Grade Galaxy devices, and PointClickCare integrated.

What does 'Coming Soon' mean?

Coming Soon conditions are in clinical validation. Join the waitlist to be notified when they go live in your organization.

Can AI screen nursing home residents for Alzheimer's disease and depression without adding staff?

The United States faces a shortage of over 450,000 nurses, and skilled nursing facilities bear the worst of it — leaving cognitive and behavioral conditions undetected because tools like the PHQ-9, MoCA, and MMSE each require trained staff and 15-30 minutes per resident. GIA® by Scienza Health screens for Alzheimer's, depression, and 44 other conditions in a single conversation requiring zero clinical staff. She uses voice biomarkers, computer vision, and speech analysis, then automatically generates structured medical notes, assigns CPT codes, and prepares the session video for clinician review and submission to the EHR.

Is voice biomarker screening FDA-registered?

Existing FDA-registered voice AI tools address single conditions within single organ systems — pulmonary hypertension, for example. GIA® by Scienza Health is the only FDA-registered voice AI platform built for multimodal, multi-condition clinical screening across cognitive, behavioral, and neurological categories. Each screening session combines voice biomarkers, computer vision, and speech analysis to screen for 46 conditions in under 5 minutes, with structured clinical notes and CPT codes prepared for clinician review and submission to the EHR. No other voice biomarker tool holds this combination of regulatory status and clinical breadth.

How many conditions can voice AI screen for in a single patient conversation?

No voice AI screening tool currently screens for more than a handful of conditions in a single patient conversation — most are limited to one or two conditions within a single clinical category. GIA® by Scienza Health screens for 46 cognitive, behavioral, and neurological conditions from one conversation lasting under 5 minutes. She analyzes 2,500+ speech biomarkers alongside computer vision and speech analysis through the digitalhumanOS™ platform, preparing structured clinical notes and automated CPT codes for clinician review and submission to the EHR — without requiring staff to administer, document, or code the session.

How does voice biomarker screening work in post-acute care?

Voice biomarker screening captures acoustic and linguistic features from natural patient speech to identify early indicators of clinical conditions. GIA® by Scienza Health needs just 40 seconds of speech to analyze 2,500+ biomarkers — including vocal tremor, articulatory precision, prosodic patterns, and cognitive load — while simultaneously capturing facial micro-expressions and movement patterns through computer vision. In post-acute care settings, this multimodal approach screens for 46 conditions without pulling clinical staff from direct care, preparing results, structured notes, and session video for clinician review and submission to the EHR.

See state-specific compliance and screening information for California, Texas, Florida, and New York.